<DOC>
	<DOCNO>NCT00167661</DOCNO>
	<brief_summary>The purpose study determine whether Campath-1H induction associate lymphocyte depletion permit long-term rejection-free renal allograft survival absence ongoing corticosteroid administration .</brief_summary>
	<brief_title>Campath-1H Induction Allow Steroid Free Immunosuppression Pediatric Renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Alemtuzumab</mesh_term>
	<criteria>1 . Male female subject , age 18 month 18 year inclusive . 2 . Subjects must singleorgan recipient ( kidney ) . 3 . Subjects receive first living donor decease donor transplant . 1 . Subjects recipients HLAidentical livingdonor renal transplant . 2 . Subjects PRA value &gt; 10 % within 30 day prior transplant . 3 . Subjects receive multiorgan transplant . 4 . Subjects positive hepatitis C , hepatitis B surface antigen HIV . 5 . Subjects receive investigational drug within 6 week study entry . 6 . Subjects previous history , currently , malignancy and/or lymphoma . 7 . Subjects receive corticosteroid within three month transplantation . 8 . Subjects 3rd transplant recipient . 9 . Female subject pregnant lactating . Fertile female subject sexually active must agree use acceptable method birth control study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>live decease donor renal transplant recipient</keyword>
</DOC>